UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 31, 2024
Accession Number:
0001437749-24-002312
Submission Type:
POS AM
CIK:
0000810509
Company Name:
NAVIDEA BIOPHARMACEUTICALS, INC.
File Number:
333-252847